Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following change in Executive Officer and other key position, effective April 1, 2020.

Change in Executive Officer

Changes in the positions assumed by Executive Officers (effective April 1, 2020)

Position as of April 1, 2020: Executive Officer Drug Development Division Executive Director, Drug Development Division Deputy Executive Director, Corporate Regulatory Compliance & Quality Assurance Division Deputy Head of Japan Business Unit

Current position: Executive Director, Drug Development Division

Name: Koichi Kozuki

Added the underlined part in the change in Executive Officer announced in our press release dated March 3, 2020.

Change in Personnel (effective April 1, 2020)

Technology Research & Development (Division)

Position as of April 1, 2020: Senior Director, Analytical Research & Development Laboratories

Current position: Director, Project Planning & Management Group, Technology Research & Development Management

Name: Yutaka Nishihara

Contact:

Tel: +81-6-6203-1407

(C) 2020 Electronic News Publishing, source ENP Newswire